About Paragonix Technologies
Paragonix Technologies is a Healthcare company based in Boston (United States) founded in 2010, and was acquired by Getinge in August 2024. Organ preservation and transport systems are developed for transplants. Paragonix Technologies has raised $25.1 million across 4 funding rounds from investors including Getinge, HHS and Signet Healthcare Partners. Its website paragonixtechnologies.com draws about 31 thousand monthly visits. Paragonix Technologies offers products and services including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App. Its focus areas include Life Sciences, Transplant Medicine, Medical Devices and Organ Preservation System. Its legal entity is Paragonix Technologies, Inc. Its competitors include TransMedics, Bridge to Life and Vascular Perfusion; 3 of its 3 listed competitors have raised funding.
Company details
Paragonix Technologies was founded in 2010 and is headquartered in Boston, United States. Operations center on the medical device sector, with development of systems for organ preservation and transport in transplantation. Intellectual property has been exclusively licensed from the Board of Regents of The University of Texas. Products include SherpaPak for hypothermic storage, SherpaKit integrating transport with preservation solutions, SherpaPerfusion for oxygenated perfusion, and SherpaTrak for organ tracking.
Products & Services of Paragonix Technologies
Paragonix Technologies offers a comprehensive portfolio of products and services, including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App.
Preserves hearts during transport with controlled temperatures
Maintains optimal conditions for lungs in transit
Ensures lung preservation through temperature monitoring
Provides perfusion for kidneys during transportation
Offers real-time tracking and monitoring for organ logistics
Apps and channels of Paragonix Technologies
its YouTube channel Paragonix Technologies has 1.53K subscribers and 30 videos.
Videos from Paragonix Technologies
The most watched videos on Paragonix Technologies's YouTube channel, Paragonix Technologies (1.53K subscribers). Click a video to play it here.
More on Paragonix Technologies.
Funding Insights of Paragonix Technologies
Paragonix Technologies has successfully raised a total of $25.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.1M
- Total Rounds 4
- Last Round Series B — $24M
- First Round $710,000
(Dec 2011)
- Investors Count 3
All 4 funding rounds of Paragonix Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $24M | Series B | – | Signet Healthcare Partners | – |
| Dec 2013 | $1.1M | Seed | – | – | – |
| Jul 2012 | $148,436 | Grant | – | – | |
| Dec 2011 | $710,000 | Debt – Conventional | – | – |
4 investors in total: 4 institutional.
Investors in Paragonix Technologies
Paragonix Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Getinge, HHS and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States | ||
Life sciences innovation is supported through funding and programs. | masslifesciences.com | Waltham, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Manufacturer of surgical lights, operating tables, and anesthesia machine | 1989 | getinge.com | Getinge, Sweden |
Investor details for Paragonix Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Paragonix Technologies
40 people are tracked at Paragonix Technologies (13 in leadership, 2 in board & advisors, 25 in team).
| Name | Role | Group |
|---|---|---|
Meredith Thompson | Director Of Area Sales | Leadership |
Lucas Churchill | Chief Innovation Officer | Leadership |
Joe Rago | Senior Director, National Accounts | Leadership |
Jen Weddell | Chief Commercial Officer | Leadership |
Lisa Anderson | Co-Founder, President & CEO | Leadership |
Chris Tomosivitch | Chief Financial Officer | Leadership |
Adam Lafreniere | Senior Director, Marketing | Leadership |
Eric J. Lanphear | Director Of Training And Logistics | Leadership |
Candy st. Marie | Vice President Of Transplant Services | Leadership |
Michala Maher | Director, Sales Operations | Leadership |
Greg Quinn | Area Director | Leadership |
Randy Koester | VP QARA | Leadership |
Danny MacAri | Director Of Research & Development | Leadership |
John Cammett | Chairman of the Board of Directors | Board & advisors |
John McDermott | Board Member | Board & advisors |
Salina Moon | Clinical Research Statistician | Team |
Samantha Estrella | Senior Product Development Engineer | Team |
Dan Rapoport | Human Factors Design Engineer | Team |
Joe Clair | Regional Territory Manager | Team |
Michael Tajima | SVP, Strategy | Team |
20 more people are available in the full profile.
Complete people profiles for Paragonix Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Paragonix Technologies
4 dated milestones of Paragonix Technologies across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Paragonix Technologies is founded.
- Funding First funding round of $710K.
- Funding Latest funding round, Series B, of $24.0M.
- Exit Acquired by Getinge.
Competitors of Paragonix Technologies
Paragonix Technologies has 3 listed competitors in our database, 3 of them funded. They include TransMedics, Bridge to Life and Vascular Perfusion.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| transmedics.com | 1998 | Andover, United States | $265.55M | 584 | Developer of organ transplantation technology | |
| bridgetolife.com | 2012 | Columbia, United States | $57M | Cold storage solutions for organ transplant preservation are provided. | ||
| vascularperfusion.solutions | 2016 | San Antonio, United States | $151.67M | Developer of a device for organ preservation |
Detailed competitors of Paragonix Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paragonix Technologies
The website of Paragonix Technologies (paragonixtechnologies.com) receives about 31.1K visits a month.
- Monthly visits31.1K
▼ 1.3% vs previous month
Top companies in Transplant Medicine
3 companies that operate in the same segment as Paragonix Technologies (Transplant Medicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical solutions for transplant patients are developed and provided. | 1998 | Brisbane, California, United States | USD 138.21 M | USD 379.81 M | 650 | |
Developer of organ transplantation technology | 1998 | Andover, Massachusetts, United States | USD 265.55 M | USD 605.49 M | 728 | |
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paragonix Technologies
Complete news archive for Paragonix Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragonix Technologies
Paragonix Technologies was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Paragonix Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Paragonix Technologies is a funded company, having raised a total of $25.1M across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $710K, raised on Dec 2011.
Paragonix Technologies was founded in 2010 and is headquartered in Boston, United States. Operations center on the medical device sector, with development of systems for organ preservation and transport in transplantation. Intellectual property has been exclusively licensed from the Board of Regents of The University of Texas. Products include SherpaPak for hypothermic storage, SherpaKit integrating transport with preservation solutions, SherpaPerfusion for oxygenated perfusion, and SherpaTrak for organ tracking.
Paragonix Technologies's top competitors include TransMedics, Bridge to Life and Vascular Perfusion.
Paragonix Technologies offers SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App.
Paragonix Technologies has 4 investors. Key investors include Getinge, HHS, Signet Healthcare Partners, and Massachusetts Life Sciences Center.
Paragonix Technologies operates through Paragonix Technologies, Inc.
Yes. Paragonix Technologies was acquired by Getinge in August 2024.